• Policy
• Bavencio by Merck passed the Cancer Drugs Benefit Committee
• by Lee, Tak-Sun Apr 8, 2022 06:08am

• Company
• Yuhan's gastric atony tx has completed the registration
• by Nho, Byung Chul Apr 8, 2022 06:08am

• Policy
• Phase 3 of Voclosporin has been approved in Korea
• by Lee, Hye-Kyung Apr 7, 2022 06:10am

• Opinion
• [Reporter’s View] Deleting exemptions for industry dev.
• by Lee, Jeong-Hwan Apr 7, 2022 06:10am

• Company
• Organon Korea "No NDPA detected in Singulair”
• by Apr 7, 2022 06:10am

• Company
• Competition for Pelubi's generics worth ₩30 billion
• by Kim, Jin-Gu Apr 7, 2022 06:10am

• Policy
• The negotiation period for patent expired drugs ,shortened
• by Lee, Jeong-Hwan Apr 7, 2022 06:10am

• Policy
• 76 generics for DM tx Jardiance Duo have been approved
• by Lee, Hye-Kyung Apr 6, 2022 06:06am

• Opinion
• [Reporter’s View] Still no news on SGLT-2 combo reimb.
• by Eo, Yun-Ho Apr 6, 2022 06:06am

• Policy
• Oral COVID-19 drugs prescribed to 1 in 100 patients
• by Lee, Jeong-Hwan Apr 6, 2022 06:06am